Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know

December 06, 2023 • 00:24:43
Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know
COR2ED - Oncology Medical Conversation
Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know

Dec 06 2023 | 00:24:43

/

Show Notes

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria in Malaga in Spain, discuss ‘The potential of PARP inhibitors in prostate cancer: What nurses need to know’. 

In this podcast, the experts discuss PARP inhibitors (PARPi’s), how they work and key data from the registration trials for rucaparib and olaparib, TRITON2 and PROfound.  They also discuss how to select PARPi’s for their prostate cancer patients and where they fit in the overall treatment sequence. Pablo provides some insight into communicating with patients, and the types of questions and concerns they often have in relation to genetic testing and treatment with PARPi’s.  In addition, they also discuss the PARPi’s currently in late-stage development such as niraparib and talazoparib as well as the potential future use of PARPi’s in combination with immunotherapies or androgen receptor pathway inhibitors.

Other Episodes

Episode

March 31, 2025 • 00:13:43
Episode Cover

ER+ metastatic breast cancer: Key insights on elacestrant from the latest EMERALD subgroup analyses

In this podcast, Dr Aditya Bardia and Dr Virginia Kaklamani share their insights on the recent publication of the subgroup analyses from the phase...

Listen

Episode

November 07, 2025 • 00:27:28
Episode Cover

Understanding EP-NEC: Through Diagnosis, Treatment, and Support

In this podcast, Medical Oncologist, Dr Aman Chauhan and Neuroendocrine Patient Advocate, Susan Meckler-Plummer, discuss extrapulmonary high-grade neuroendocrine carcinomas (EP-NECs), a rare, aggressive, and...

Listen

Episode

December 06, 2023 • 00:26:17
Episode Cover

Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges

In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for...

Listen